Progyny (PGNY) Shares Outstanding (Weighted Average) (2018 - 2026)

Progyny (PGNY) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $80.9 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) fell 5.35% year-over-year to $80.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.9 million (down 5.35% YoY) and the FY2025 annual result came in at $85.2 million, down 0.67% from the prior year.
• Shares Outstanding (Weighted Average) fell to $80.9 million in Q1 2026 per PGNY's latest filing, from $85.2 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $96.5 million in Q1 2024 and bottomed at $80.9 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $92.0 million (2022), against an average of $90.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) grew 4.58%; it then fell 11.39% in 2025.
• Tracing PGNY's Shares Outstanding (Weighted Average) over 5 years: stood at $92.2 million in 2022, then gained by 3.07% to $95.0 million in 2023, then decreased by 9.69% to $85.8 million in 2024, then decreased by 0.67% to $85.2 million in 2025, then fell by 5.06% to $80.9 million in 2026.
• Per Business Quant, the three latest PGNY Shares Outstanding (Weighted Average) figures stand at $80.9 million (Q1 2026), $85.2 million (Q4 2025), and $86.0 million (Q3 2025).

Peer Comparison